10-Q Filing

TENET HEALTHCARE CORP CIK: 70318 Q1 2018

Filing Information

Form Type	10-Q
Accession Number	`0000070318-18-000018`
Period End Date	20180331
Filing Date	20180430
Fiscal Year	2018
Fiscal Period	Q1
XBRL Instance	thc-20180331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 93 Income Statement 71 Cash Flow Statement 94 Comprehensive Income 20

Balance Sheet 93 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$898.00M	USD	Point-in-time
Property and equipment, accumulated depreciation and amortization	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.88B	USD	Point-in-time
Property and equipment, accumulated depreciation and amortization	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.74B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$716.00M	USD	Point-in-time
Other intangible assets, accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$883.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$974.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$611.00M	USD	Point-in-time
Other intangible assets, accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$920.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$572.00M	USD	Point-in-time
Accounts receivable (less allowance for doubtful accounts of $898 at December 31, 2017)	`AccountsReceivableNetCurrent`	$2.52B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.05	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.05	USD	Point-in-time
Accounts receivable (less allowance for doubtful accounts of $898 at December 31, 2017)	`AccountsReceivableNetCurrent`	$2.62B	USD	Point-in-time
Common stock, authorized shares (in shares)	`CommonStockSharesAuthorized`	262.50M	shares	Point-in-time
Inventories of supplies, at cost	`InventoryNet`	$289.00M	USD	Point-in-time
Inventories of supplies, at cost	`InventoryNet`	$294.00M	USD	Point-in-time
Common stock, authorized shares (in shares)	`CommonStockSharesAuthorized`	262.50M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	149.38M	shares	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$5.00M	USD	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$20.00M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	150.39M	shares	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$1.02B	USD	Point-in-time
Common stock in treasury (in shares)	`TreasuryStockCommonShares`	48.40M	shares	Point-in-time
Common stock in treasury (in shares)	`TreasuryStockCommonShares`	48.41M	shares	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$599.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.03B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.23B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.63B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.57B	USD	Point-in-time
Investments and other assets	`LongTermInvestmentsAndReceivablesNet`	$1.43B	USD	Point-in-time
Investments and other assets	`LongTermInvestmentsAndReceivablesNet`	$1.54B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$455.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$383.00M	USD	Point-in-time
Property and equipment, at cost, less accumulated depreciation and amortization ($4,879 at March 31, 2018 and $4,739 at December 31, 2017)	`PropertyPlantAndEquipmentNet`	$7.03B	USD	Point-in-time
Property and equipment, at cost, less accumulated depreciation and amortization ($4,879 at March 31, 2018 and $4,739 at December 31, 2017)	`PropertyPlantAndEquipmentNet`	$6.91B	USD	Point-in-time
Goodwill	`Goodwill`	$7.04B	USD	Point-in-time
Goodwill	`Goodwill`	$7.02B	USD	Point-in-time
Other intangible assets, at cost, less accumulated amortization ($920 at March 31, 2018 and $883 at December 31, 2017)	`IntangibleAssetsNetExcludingGoodwill`	$1.77B	USD	Point-in-time
Other intangible assets, at cost, less accumulated amortization ($920 at March 31, 2018 and $883 at December 31, 2017)	`IntangibleAssetsNetExcludingGoodwill`	$1.79B	USD	Point-in-time
Total assets	`Assets`	$23.18B	USD	Point-in-time
Total assets	`Assets`	$23.39B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$146.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$666.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.18B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.06B	USD	Point-in-time
Accrued compensation and benefits	`EmployeeRelatedLiabilitiesCurrent`	$708.00M	USD	Point-in-time
Accrued compensation and benefits	`EmployeeRelatedLiabilitiesCurrent`	$848.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveCurrent`	$200.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveCurrent`	$222.00M	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$332.00M	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$256.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$406.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$480.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.17B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.23B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.33B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.56B	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$14.79B	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$14.22B	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveNoncurrent`	$651.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveNoncurrent`	$654.00M	USD	Point-in-time
Defined benefit plan obligations	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$536.00M	USD	Point-in-time
Defined benefit plan obligations	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$528.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$36.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$36.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$631.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$627.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$20.98B	USD	Point-in-time
Total liabilities	`Liabilities`	$20.63B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$1.87B	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$1.94B	USD	Point-in-time
Common stock, $0.05 par value; authorized 262,500,000 shares; 150,391,400 shares issued at March 31, 2018 and 149,384,952 shares issued at December 31, 2017	`CommonStockValue`	$7.00M	USD	Point-in-time
Common stock, $0.05 par value; authorized 262,500,000 shares; 150,391,400 shares issued at March 31, 2018 and 149,384,952 shares issued at December 31, 2017	`CommonStockValue`	$7.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.86B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.83B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-204.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-239.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.25B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.39B	USD	Point-in-time
Common stock in treasury, at cost, 48,402,616 shares at March 31, 2018 and 48,413,169 shares at December 31, 2017	`TreasuryStockCommonValue`	$2.42B	USD	Point-in-time
Common stock in treasury, at cost, 48,402,616 shares at March 31, 2018 and 48,413,169 shares at December 31, 2017	`TreasuryStockCommonValue`	$2.42B	USD	Point-in-time
Total shareholders equity (deficit)	`StockholdersEquity`	$-65.00M	USD	Point-in-time
Total shareholders equity (deficit)	`StockholdersEquity`	$-147.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$681.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$686.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$616.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$539.00M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$23.18B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$23.39B	USD	Point-in-time

Income Statement 71 line items

Line Item	Tag	Value	Unit	Period
Net operating revenues before provision for doubtful accounts	`HealthCareOrganizationRevenue`	$5.20B	USD	1 Quarter
Less: Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$383.00M	USD	1 Quarter
Less: Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	-	USD	1 Quarter
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$4.70B	USD	1 Quarter
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$4.81B	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$29.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$25.00M	USD	1 Quarter
Salaries, wages and benefits	`LaborAndRelatedExpense`	$2.38B	USD	1 Quarter
Salaries, wages and benefits	`LaborAndRelatedExpense`	$2.23B	USD	1 Quarter
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$774.00M	USD	1 Quarter
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$765.00M	USD	1 Quarter
Other operating expenses, net	`OtherCostAndExpenseOperating`	$1.06B	USD	1 Quarter
Other operating expenses, net	`OtherCostAndExpenseOperating`	$1.19B	USD	1 Quarter
Electronic health record incentives	`ElectronicHealthRecordIncentives`	$1.00M	USD	1 Quarter
Electronic health record incentives	`ElectronicHealthRecordIncentives`	$1.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$204.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$221.00M	USD	1 Quarter
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$47.00M	USD	1 Quarter
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$33.00M	USD	1 Quarter
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-5.00M	USD	1 Quarter
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-6.00M	USD	1 Quarter
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$15.00M	USD	1 Quarter
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$110.00M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$267.00M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$517.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$258.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$255.00M	USD	1 Quarter
Other non-operating expense, net	`OtherNonoperatingIncomeExpense`	$-1.00M	USD	1 Quarter
Other non-operating expense, net	`OtherNonoperatingIncomeExpense`	$-5.00M	USD	1 Quarter
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.00M	USD	1 Quarter
Income from continuing operations, before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.00M	USD	1 Quarter
Income from continuing operations, before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$260.00M	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-33.00M	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$70.00M	USD	1 Quarter
Income from continuing operations, before discontinued operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$190.00M	USD	1 Quarter
Income from continuing operations, before discontinued operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$37.00M	USD	1 Quarter
Income (loss) from operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax`	$-2.00M	USD	1 Quarter
Income (loss) from operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax`	$1.00M	USD	1 Quarter
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	-	USD	1 Quarter
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$-1.00M	USD	1 Quarter
Income (loss) from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$1.00M	USD	1 Quarter
Income (loss) from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.00M	USD	1 Quarter
Net income	`ProfitLoss`	$36.00M	USD	1 Quarter
Net income	`ProfitLoss`	$191.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$89.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$92.00M	USD	1 Quarter
Net income available (loss attributable) to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$99.00M	USD	1 Quarter
Net income available (loss attributable) to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-53.00M	USD	1 Quarter
Income (loss) from continuing operations, net of tax	`IncomeLossFromContinuingOperations`	$98.00M	USD	1 Quarter
Income (loss) from continuing operations, net of tax	`IncomeLossFromContinuingOperations`	$-52.00M	USD	1 Quarter
Income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$1.00M	USD	1 Quarter
Income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-1.00M	USD	1 Quarter
Net income available (loss attributable) to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$99.00M	USD	1 Quarter
Net income available (loss attributable) to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-53.00M	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.97	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.52	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$0.01	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.01	USD	1 Quarter
Total loss per share, Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.53	USD	1 Quarter
Total loss per share, Basic (in dollars per share)	`EarningsPerShareBasic`	$0.98	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.52	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.95	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.01	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$0.01	USD	1 Quarter
Total loss per share, Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.96	USD	1 Quarter
Total loss per share, Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.53	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	101.39M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	100.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	102.66M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	100.00M	shares	1 Quarter

Cash Flow Statement 94 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$36.00M	USD	1 Quarter
Net income	`ProfitLoss`	$191.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$204.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$221.00M	USD	1 Quarter
Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$383.00M	USD	1 Quarter
Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	-	USD	1 Quarter
Deferred income tax expense (benefit)	`DeferredIncomeTaxExpenseBenefit`	$70.00M	USD	1 Quarter
Deferred income tax expense (benefit)	`DeferredIncomeTaxExpenseBenefit`	-	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$13.00M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$9.00M	USD	1 Quarter
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$47.00M	USD	1 Quarter
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$33.00M	USD	1 Quarter
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-5.00M	USD	1 Quarter
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-6.00M	USD	1 Quarter
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$15.00M	USD	1 Quarter
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$110.00M	USD	1 Quarter
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$-9.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$-4.00M	USD	1 Quarter
Amortization of debt discount and debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$11.00M	USD	1 Quarter
Amortization of debt discount and debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$11.00M	USD	1 Quarter
Pre-tax loss (income) from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$1.00M	USD	1 Quarter
Pre-tax loss (income) from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-2.00M	USD	1 Quarter
Other items, net	`OtherNoncashIncomeExpense`	$1.00M	USD	1 Quarter
Other items, net	`OtherNoncashIncomeExpense`	$2.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$446.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$66.00M	USD	1 Quarter
Inventories and other current assets	`IncreaseDecreaseInInventoriesAndOtherAssetsCurrent`	$-132.00M	USD	1 Quarter
Inventories and other current assets	`IncreaseDecreaseInInventoriesAndOtherAssetsCurrent`	$41.00M	USD	1 Quarter
Income taxes	`IncreaseDecreaseInIncomeTaxesReceivable`	-	USD	1 Quarter
Income taxes	`IncreaseDecreaseInIncomeTaxesReceivable`	$34.00M	USD	1 Quarter
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-161.00M	USD	1 Quarter
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-183.00M	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$1.00M	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$26.00M	USD	1 Quarter
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements	`PaymentsForRestructuringAndLitigationCosts`	$33.00M	USD	1 Quarter
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements	`PaymentsForRestructuringAndLitigationCosts`	$24.00M	USD	1 Quarter
Net cash provided by (used in) operating activities from discontinued operations, excluding income taxes	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$2.00M	USD	1 Quarter
Net cash provided by (used in) operating activities from discontinued operations, excluding income taxes	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-1.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$186.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$113.00M	USD	1 Quarter
Purchases of property and equipment continuing operations	`PaymentsToAcquirePropertyPlantAndEquipment`	$198.00M	USD	1 Quarter
Purchases of property and equipment continuing operations	`PaymentsToAcquirePropertyPlantAndEquipment`	$143.00M	USD	1 Quarter
Purchases of businesses or joint venture interests, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$16.00M	USD	1 Quarter
Purchases of businesses or joint venture interests, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$6.00M	USD	1 Quarter
Proceeds from sales of facilities and other assets	`ProceedsFromDivestitureOfBusinesses`	$425.00M	USD	1 Quarter
Proceeds from sales of facilities and other assets	`ProceedsFromDivestitureOfBusinesses`	$20.00M	USD	1 Quarter
Proceeds from sales of marketable securities, long-term investments and other assets	`ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets`	$134.00M	USD	1 Quarter
Proceeds from sales of marketable securities, long-term investments and other assets	`ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets`	$9.00M	USD	1 Quarter
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$30.00M	USD	1 Quarter
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$1.00M	USD	1 Quarter
Other long-term assets	`PaymentsForProceedsFromProductiveAssets`	$-7.00M	USD	1 Quarter
Other long-term assets	`PaymentsForProceedsFromProductiveAssets`	$12.00M	USD	1 Quarter
Other items, net	`PaymentsForProceedsFromOtherInvestingActivities`	$4.00M	USD	1 Quarter
Other items, net	`PaymentsForProceedsFromOtherInvestingActivities`	$1.00M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$373.00M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-189.00M	USD	1 Quarter
Repayments of borrowings under credit facility	`RepaymentsOfLongTermLinesOfCredit`	-	USD	1 Quarter
Repayments of borrowings under credit facility	`RepaymentsOfLongTermLinesOfCredit`	-	USD	1 Quarter
Proceeds from borrowings under credit facility	`ProceedsFromLongTermLinesOfCredit`	-	USD	1 Quarter
Proceeds from borrowings under credit facility	`ProceedsFromLongTermLinesOfCredit`	-	USD	1 Quarter
Repayments of other borrowings	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$91.00M	USD	1 Quarter
Repayments of other borrowings	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$89.00M	USD	1 Quarter
Proceeds from other borrowings	`ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet`	$6.00M	USD	1 Quarter
Proceeds from other borrowings	`ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet`	$7.00M	USD	1 Quarter
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$2.00M	USD	1 Quarter
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	1 Quarter
Distributions paid to noncontrolling interests	`PaymentsOfDividendsMinorityInterest`	$64.00M	USD	1 Quarter
Distributions paid to noncontrolling interests	`PaymentsOfDividendsMinorityInterest`	$63.00M	USD	1 Quarter
Proceeds from sales of noncontrolling interests	`ProceedsFromSaleOfInterestInCorporateUnit`	$10.00M	USD	1 Quarter
Proceeds from sales of noncontrolling interests	`ProceedsFromSaleOfInterestInCorporateUnit`	$5.00M	USD	1 Quarter
Purchases of noncontrolling interests	`PaymentsToMinorityShareholders`	$9.00M	USD	1 Quarter
Purchases of noncontrolling interests	`PaymentsToMinorityShareholders`	-	USD	1 Quarter
Proceeds from exercise of stock options and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$2.00M	USD	1 Quarter
Proceeds from exercise of stock options and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$9.00M	USD	1 Quarter
Other items, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$20.00M	USD	1 Quarter
Other items, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-5.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-141.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-123.00M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-144.00M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$363.00M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$716.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$974.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$611.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$572.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$716.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$974.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$611.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$572.00M	USD	Point-in-time
Interest paid, net of capitalized interest	`InterestPaidNet`	$169.00M	USD	1 Quarter
Interest paid, net of capitalized interest	`InterestPaidNet`	$130.00M	USD	1 Quarter
Income tax refunds (payments), net	`IncomeTaxesPaidNet`	$-1.00M	USD	1 Quarter
Income tax refunds (payments), net	`IncomeTaxesPaidNet`	$1.00M	USD	1 Quarter

Comprehensive Income 20 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$36.00M	USD	1 Quarter
Net income	`ProfitLoss`	$191.00M	USD	1 Quarter
Amortization of net actuarial loss included in other non-operating expense, net	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax`	$4.00M	USD	1 Quarter
Amortization of net actuarial loss included in other non-operating expense, net	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax`	$4.00M	USD	1 Quarter
Unrealized gains on securities held as available-for-sale	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	-	USD	1 Quarter
Unrealized gains on securities held as available-for-sale	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$2.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$6.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$3.00M	USD	1 Quarter
Other comprehensive income before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$9.00M	USD	1 Quarter
Other comprehensive income before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$10.00M	USD	1 Quarter
Income tax expense related to items of other comprehensive income	`OtherComprehensiveIncomeLossTax`	$6.00M	USD	1 Quarter
Income tax expense related to items of other comprehensive income	`OtherComprehensiveIncomeLossTax`	$2.00M	USD	1 Quarter
Total other comprehensive income, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$3.00M	USD	1 Quarter
Total other comprehensive income, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$8.00M	USD	1 Quarter
Comprehensive net income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$199.00M	USD	1 Quarter
Comprehensive net income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$39.00M	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$89.00M	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$92.00M	USD	1 Quarter
Comprehensive income available (loss attributable) to Tenet Healthcare Corporation common shareholders	`ComprehensiveIncomeNetOfTax`	$-50.00M	USD	1 Quarter
Comprehensive income available (loss attributable) to Tenet Healthcare Corporation common shareholders	`ComprehensiveIncomeNetOfTax`	$107.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.